The Science Advisory Board has conducted opinion research regarding The Food & Drug Administration (FDA), and federal regulations’ effect on drug prices. This survey talks about the Trump Administration’s proposed budget cuts and policy changes that would affect the FDA. It also enquires about Scott Gottlieb’s nomination to lead the agency, the FDA’s approval process and probe at the causes of increasing drug prices.
This opinion research project is part of an internship program in partnership with the Biotechnology Graduate Program of Georgetown University. Ran Xu, graduate student at Georgetown University, conduct this opinion research with Quentin Kreilmann, Manager of The Scientific Advisory Board.